Fig. 1From: Chemoradiation treatment with or without concurrent tumor-treating fields (TTFields) therapy in newly diagnosed glioblastoma (GBM) patients in ChinaComparison of progression-free survival (A) and overall survival (B) between CA-TTF and A-TTF groupsBack to article page